ZyGEM NZ Limited is a biotechnology company with innovative technologies that have applications in a broad range of life sciences and nucleic acids diagnostics The company is a world leader in identifying enzymes extracted from extremophiles (microorganisms from extreme environments) and using these for a wide range of applications.
The company was created in 2005 as a spin-off from commercial and academic R&D going back to the mid 80's. Its foundation was based on 25 years of research into extremophiles and the central resource of the reagents side of the business is an extraordinary collection of cultured bacteria, archaea and fungi isolated in environments ranging from 0° to 106°C.
ZyGEM focuses on high-value products for basic research, forensics and molecular diagnostics. It produces innovative DNA extraction products, as well as enzymes used in molecular biology, diagnostics and industrial applications.
ZyGEM products have established a reputation for quality and innovation that provide important benefits to customers. For example, the company’s flagship DNA extraction and detection family of products significantly increases the speed, yield and accuracy of the analytic process. ZyGEM is adding new technologies, products and product line extensions to its offerings and is expanding its geographic and industry reach.
ZyGEM NZ is now under new management and is actively pursuing new markets in Asia. With its sister company, MicroLab Diagnostics (USA) we are well advanced in the development of new diagnostic tools including low-cost, rapid sampling and DNA extraction devices.
The reagents of ZyGEM (Hamilton, NZ) and the microfluidics technology of MicroLab (Charlottesville, USA) have re-emerged under the umbrella of MicroGEM International PLC. At the helm of this new venture are, Richard Healey and Jonathan Sims, who bring a wealth of corporate management and manufacturing expertise. MicroGEM is pleased to build upon the work of its subsidiaries by providing novel reagents and microfluidic instrumentation to the forensic and clinical sectors, while developing reagents and technologies for new markets, including the agricultural and veterinary industries.
MicroGEM continues to develop instruments and consumables to simplify Nucleic Acid analysis in the laboratory and beyond. Products in development will provide forensic laboratories with new tools to address backlog and incoming samples.
Newly formed Board of Directors for MicroGEM International PLC. Left to right: James Landers, Richard Healey, Jonathan Sims, Martin Goddard, David Saul (Absent: Garth Smith)
• Small samples where purification steps are not feasible
• Low copy number and single cell DNA/RNA extraction
• Rare or precious samples that must not be contaminated
• Hazardous samples where the user must be protected
• Automation where columns and beads are not feasible
• High throughput automation
• Cost-sensitive diagnostics
• Small volumes = high yields for small samples
• No purification steps needed for most applications = high yields
• Closed tube means that sample is protected from contamination
• Closed-tube. Ihe user is protected from hazardous samples
• Easily automated on off-the-shelf robots
• Low cost in reagents, reduces consumables and technician time
• The lowest amount of plastic waste in the business.
(c) 2015 ZyGEM NZ Ltd